| Thromboembolism |
0 |
0.94 |
| Pregnancy |
0 |
0.82 |
| Antiphospholipid Syndrome |
0 |
1 |
| Renal Disease |
0 |
0.41 |
| Hospital |
0 |
0.36 |
| Thrombosis |
0 |
0.36 |
| Pulmonary Embolism |
0 |
0.34 |
| Kidney |
0 |
0.27 |
| New York |
0 |
0.27 |
| Thrombocytopenia |
0 |
0.24 |
| Attending Physician |
0 |
0.18 |
| Europe |
0 |
0.18 |
| Massachusetts |
0 |
0.18 |
| Surgery |
0 |
0.18 |
| Cardiovascular Risk Management |
0 |
0.16 |
| Immunoglobulin G (IgG) |
0 |
0.15 |
| Platelet Count |
0 |
0.15 |
| Venous Thromboembolism (VTE) |
0 |
0.15 |
| Premature Birth |
0 |
0.13 |
| Anticoagulation Therapy |
0 |
0.09 |
| Birth |
0 |
0.09 |
| Cardiovascular disease |
0 |
0.09 |
| Coagulation |
0 |
0.09 |
| Embolism |
0 |
0.09 |
| Enzyme-Linked Immunosorbent Assay (ELISA) |
0 |
0.09 |
| Heart |
0 |
0.09 |
| Immunoglobulin A (IgA) |
0 |
0.09 |
| Lupus |
0 |
0.09 |
| Perinatal Mortality |
0 |
0.09 |
| Preeclampsia |
0 |
0.09 |
| Systemic Lupus Erythematosus |
0 |
0.08 |